140 related articles for article (PubMed ID: 2177429)
1. [Repermeability of portal vein after intra-arterial lipiodol chemotherapy in patients with hepatocellular carcinoma. Report of 3 cases].
Derhy S; Bessis L; Atallah R; Ajavon Y; Eisele G; Roche A
Gastroenterol Clin Biol; 1990; 14(11):893-5. PubMed ID: 2177429
[No Abstract] [Full Text] [Related]
2. Intra-arterial therapy with cisplatin suspension in lipiodol and 5-fluorouracil for hepatocellular carcinoma with portal vein tumour thrombosis.
Nagamatsu H; Hiraki M; Mizukami N; Yoshida H; Iwamoto H; Sumie S; Torimura T; Sata M
Aliment Pharmacol Ther; 2010 Aug; 32(4):543-50. PubMed ID: 20500734
[TBL] [Abstract][Full Text] [Related]
3. Randomized controlled trial for hepatocellular carcinoma with portal vein thrombosis: intra-arterial iodine-131-iodized oil versus medical support.
Raoul JL; Guyader D; Bretagne JF; Duvauferrier R; Bourguet P; Bekhechi D; Deugnier YM; Gosselin M
J Nucl Med; 1994 Nov; 35(11):1782-7. PubMed ID: 7525901
[TBL] [Abstract][Full Text] [Related]
4. [Transcatheter arterial infusion therapy using lipiodol and mitomycin C for hepatocellular carcinoma with liver cirrhosis].
Adachi S; Todoroki T; Ishikawa A; Nosue M; Fukao K; Iwasaki Y; Saida Y; Yamaguchi T; Osuga T; Doi M
Nihon Gan Chiryo Gakkai Shi; 1988 Aug; 23(8):1710-9. PubMed ID: 2848081
[No Abstract] [Full Text] [Related]
5. [Effect of combination therapy with an adriamycin-lipiodol emulsion and a mitomycin C microcapsule in hepatocellular carcinoma complicated by portal thrombosis].
Takagi H; Abe T; Uehara M; Saitoh S; Takayama H; Ojima T; Iizuka H; Katakai S; Takezawa J; Nagamine T
Gan No Rinsho; 1988 Mar; 34(3):347-55. PubMed ID: 2833637
[TBL] [Abstract][Full Text] [Related]
6. [Effect of low dose 5-fluorouracil and cisplatin intra-arterial infusion chemotherapy in advanced hepatocellular carcinoma with decompensated cirrhosis].
Lim TY; Cheong JY; Cho SW; Sim SJ; Kim JS; Choi SJ; Choi JW; Kwon HC; Lee KM; Kim JK; Won JH; Yoo BM; Lee KJ; Hahm KB; Kim JH
Korean J Hepatol; 2006 Mar; 12(1):65-73. PubMed ID: 16565607
[TBL] [Abstract][Full Text] [Related]
7. Therapy of hepatocellular cancer with iodine-131-Lipiodol.
Risse JH; Menzel C; Grünwald F; Strunk H; Biersack HJ; Palmedo H
Rom J Gastroenterol; 2004 Jun; 13(2):119-24. PubMed ID: 15229776
[TBL] [Abstract][Full Text] [Related]
8. Unusual atrophic change after repeated arterial therapy for hepatocellular carcinoma: report of a case.
Komori T; Sasaki Y; Yamada T; Ohigashi H; Ishikawa O; Inoue E; Ishiguro S; Seki T; Imaoka S
Surg Today; 2004; 34(1):76-9. PubMed ID: 14714235
[TBL] [Abstract][Full Text] [Related]
9. Iodized oil in the portal vein after arterial embolization.
Nakamura H; Hashimoto T; Oi H; Sawada S
Radiology; 1988 May; 167(2):415-7. PubMed ID: 2833765
[TBL] [Abstract][Full Text] [Related]
10. [Intra-arterial injection of cisplatin suspension in lipiodol (LPS) for the treatment of advanced hepatocellular carcinoma (stage IV)].
Shibata J; Kimura S; Nakashima M; Nakazono K; Miyase S; Sakai M; Fujiyama S; Sato T
Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 1):357-64. PubMed ID: 2539053
[TBL] [Abstract][Full Text] [Related]
11. Prospective randomized trial of chemoembolization versus intra-arterial injection of 131I-labeled-iodized oil in the treatment of hepatocellular carcinoma.
Raoul JL; Guyader D; Bretagne JF; Heautot JF; Duvauferrier R; Bourguet P; Bekhechi D; Deugnier YM; Gosselin M
Hepatology; 1997 Nov; 26(5):1156-61. PubMed ID: 9362356
[TBL] [Abstract][Full Text] [Related]
12. [Hepatocellular carcinoma with cirrhosis: treatment with doxorubicin. Phase II evaluation].
Barbare JC; Ballet F; Petit J; Poupon R; Darnis F
Bull Cancer; 1984; 71(5):442-5. PubMed ID: 6084528
[TBL] [Abstract][Full Text] [Related]
13. [Effect of arterial injection of lipiodol-adriamycin emulsion on hepatocellular carcinoma].
Sonoyama T; Hironaka T; Inaba S; Tsukamoto K; Nonaka M; Makino H; Kohnosu H; Oka T
Nihon Gan Chiryo Gakkai Shi; 1986 May; 21(4):773-9. PubMed ID: 3020138
[No Abstract] [Full Text] [Related]
14. [Hepatic arterial infusion chemotherapy of hepatocellular carcinoma].
Ishibashi T; Okajima K; Isozaki H; Morita S; Nakata E; Nishimura J; Iga C; Amioka K; Tanimura M; Hara H
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2778-81. PubMed ID: 2551222
[TBL] [Abstract][Full Text] [Related]
15. Prevention of intrahepatic recurrence by adjuvant (131)iodine-labeled lipiodol after resection for hepatocellular carcinoma in HCV-related cirrhosis.
Tabone M; Vigano' L; Ferrero A; Pellerito R; Carbonatto P; Capussotti L
Eur J Surg Oncol; 2007 Feb; 33(1):61-6. PubMed ID: 17175128
[TBL] [Abstract][Full Text] [Related]
16. [Repeated arterial infusion of zinostatin stimalamer using port for advanced hepatocellular carcinoma].
Yoshikawa M; Ebara M; Fukuda H; Sugiura N; Saisho H
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():30-3. PubMed ID: 9512684
[TBL] [Abstract][Full Text] [Related]
17. Chemolipiodolization and prostaglandin E1 administration with use of hepatic arterial infusion port for the treatment of hepatocellular carcinoma and liver cirrhosis.
Kakizoe S; Kakizoe K; Kakizoe Y; Kakizoe H; Kakizoe T; Kakizoe S
Hepatogastroenterology; 1996; 43(11):1377-82. PubMed ID: 8908577
[TBL] [Abstract][Full Text] [Related]
18. [Hepatic artery and portal vein dual perfusion chemotherapy in combination with injection of lipiodol-ethanol in treatment of advanced primary hepatocellular carcinoma].
An Y; Bie P; Dong J
Zhonghua Wai Ke Za Zhi; 2001 Aug; 39(8):593-5. PubMed ID: 11758194
[TBL] [Abstract][Full Text] [Related]
19. [Hepatocellular carcinoma with a complete remission of bone metastasis achieved by arterial chemotherapy].
Fukushima H; Hirai K; Shimada M; Aoki Y; Iwai I; Yamashita K; Fujimoto T; Tanaka M; Majima Y; Nakashima O
Gan No Rinsho; 1990 Sep; 36(11):2059-62. PubMed ID: 2172585
[TBL] [Abstract][Full Text] [Related]
20. Without victory there is no survival: transarterial lipiodol chemoembolization and hepatocellular carcinoma.
Sudan D; Sudan R; Schafer D; Langnas A
Hepatology; 1998 Jul; 28(1):270-1. PubMed ID: 9657124
[No Abstract] [Full Text] [Related]
[Next] [New Search]
